WallStreetZenWallStreetZen

NASDAQ: THTX
Theratechnologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their THTX stock forecasts and price targets.

Forecast return on equity

Is THTX forecast to generate an efficient return?

Company
-115.56%
Industry
140.91%
Market
90.47%
THTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is THTX forecast to generate an efficient return on assets?

Company
50.08%
Industry
32.45%
THTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

THTX earnings per share forecast

What is THTX's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.17
Avg 2 year Forecast
$0.12
Avg 3 year Forecast
$0.20

THTX revenue forecast

What is THTX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$83.9M+34.37%
Avg 2 year Forecast
$93.7M+50.06%
Avg 3 year Forecast
$95.6M+53.1%
THTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

THTX revenue growth forecast

How is THTX forecast to perform vs Biotechnology companies and vs the US market?

Company
16.05%
Industry
56.38%
Market
9.68%
THTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
THTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

THTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
THTX$2.48N/AN/A
SGMO$0.49$4.50+816.50%Buy
CTNM$4.43$22.50+407.90%Strong Buy
ACHV$3.25N/AN/A
GNLX$3.06$26.50+766.01%Buy
View Top Biotech Stocks

Theratechnologies Stock Forecast FAQ

What is THTX's earnings growth forecast for 2025-2027?

(NASDAQ: THTX) Theratechnologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Theratechnologies's earnings in 2025 is -$2,593,006.On average, 1 Wall Street analyst forecast THTX's earnings for 2025 to be -$7,816,603, with the lowest THTX earnings forecast at -$7,816,603, and the highest THTX earnings forecast at -$7,816,603. On average, 1 Wall Street analyst forecast THTX's earnings for 2026 to be $5,517,602, with the lowest THTX earnings forecast at $5,517,602, and the highest THTX earnings forecast at $5,517,602.

In 2027, THTX is forecast to generate $9,196,004 in earnings, with the lowest earnings forecast at $9,196,004 and the highest earnings forecast at $9,196,004.

If you're new to stock investing, here's how to buy Theratechnologies stock.

What is THTX's revenue growth forecast for 2025-2027?

(NASDAQ: THTX) Theratechnologies's forecast annual revenue growth rate of 16.05% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Theratechnologies's revenue in 2025 is $62,004,195.On average, 1 Wall Street analysts forecast THTX's revenue for 2025 to be $3,857,723,594, with the lowest THTX revenue forecast at $3,857,723,594, and the highest THTX revenue forecast at $3,857,723,594. On average, 1 Wall Street analysts forecast THTX's revenue for 2026 to be $4,308,327,780, with the lowest THTX revenue forecast at $4,308,327,780, and the highest THTX revenue forecast at $4,308,327,780.

In 2027, THTX is forecast to generate $4,395,689,816 in revenue, with the lowest revenue forecast at $4,395,689,816 and the highest revenue forecast at $4,395,689,816.

What is THTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: THTX) forecast ROA is 50.08%, which is higher than the forecast US Biotechnology industry average of 32.45%.

What is THTX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: THTX) Theratechnologies's current Earnings Per Share (EPS) is -$0.06. On average, analysts forecast that THTX's EPS will be -$0.17 for 2025, with the lowest EPS forecast at -$0.17, and the highest EPS forecast at -$0.17. On average, analysts forecast that THTX's EPS will be $0.12 for 2026, with the lowest EPS forecast at $0.12, and the highest EPS forecast at $0.12. In 2027, THTX's EPS is forecast to hit $0.20 (min: $0.20, max: $0.20).

What is THTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: THTX) forecast ROE is -115.56%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.